Sleeve Gastrectomy in Different Age Groups: a Comparative Study of 5-Year Outcomes

Background Laparoscopic sleeve gastrectomy (LSG) has been used more frequently over the past 10 years. As the population ages, a larger number of older people will suffer from weight-related comorbidities, resulting in bariatric surgery becoming a dominant solution for improving health and quality o...

Full description

Saved in:
Bibliographic Details
Published inObesity surgery Vol. 26; no. 2; pp. 289 - 295
Main Authors Keren, D., Matter, I., Rainis, T.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.02.2016
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Laparoscopic sleeve gastrectomy (LSG) has been used more frequently over the past 10 years. As the population ages, a larger number of older people will suffer from weight-related comorbidities, resulting in bariatric surgery becoming a dominant solution for improving health and quality of life. We assessed the long-term outcomes of LSG in elderly patients. Methods We conducted a retrospective chart review of patients who underwent LSG between January 2007 and August 2009. We subdivided 123 patients into <35 ( n  = 43), 35–55 ( n  = 59), and >55 ( n  = 21) age groups. Results The respective mean excess body mass index loss and excess weight loss were 42.5 % ± 3.1 % and 41.3 % ± 12.3 % for the <35 age group, 48.7 % ± 4.1 % and 45.6 % ± 10.6 % for the 35–55 age group, and 53.6 % ± 4.6 % and 52.1 % ± 11.1 % for the >55 age group. The follow-up compliance rates at the 5-year visit were 23.85, 31.11, and 47.61 % for the <35, 35–55, and >55 age groups, respectively. The corresponding Bariatric Analysis and Reporting Outcome System scores were 3.7 ± 1.1, 4.0 ± 0.7, and 5.3 ± 1.3. The comorbidities of all the patients improved significantly, with a non-significant distribution between the three groups for each comorbidity. Conclusions LSG is a useful tool for people who want to modify their eating habits and lose weight healthily. This study suggests that long-term weight loss, improvements in comorbidity, and compliance to follow-up are significant for patients >55 years old.
ISSN:0960-8923
1708-0428
DOI:10.1007/s11695-015-1735-2